Guardian Pharmacy Services, Inc.GRDN
About: Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.
Employees: 3,400
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
83% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 18
37% more capital invested
Capital invested by funds: $142M [Q3] → $194M (+$52.4M) [Q4]
29% more funds holding
Funds holding: 51 [Q3] → 66 (+15) [Q4]
0% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 15
1.1% less ownership
Funds ownership: 105.31% [Q3] → 104.2% (-1.1%) [Q4]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
Truist Securities David Macdonald 60% 1-year accuracy 60 / 100 met price target | 8%upside $25 | Buy Maintained | 11 Apr 2025 |
Financial journalist opinion
Based on 3 articles about GRDN published over the past 30 days









